Heverlee, Belgium

F Peluso

This inventor holds 1 USPTO granted patent. Top assignee: Baxter International Inc.. Active years: 1998.


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 39(Granted Patents)


Company Filing History:


Years Active: 1998

Loading Chart...
1 patent (USPTO):Explore Patents

Title: F Peluso: Innovator in Antimicrobial Technology

Introduction

F Peluso is a notable inventor based in Heverlee, Belgium. He has made significant contributions to the field of antimicrobial technology, particularly through his innovative patent that addresses the need for sterile connections in various applications.

Latest Patents

Peluso holds a patent for a "Method and device for precise release of an antimicrobial agent." This invention presents an improved system and method for providing sterile connections. The device comprises a body and a chamber defined, at least in part, by a portion of the body. The chamber includes an interior that houses a solid sterilizing agent capable of sublimating at ambient conditions. Additionally, a member partially defines the chamber and is designed to allow the solid sterilizing agent to release in a rate-controlled manner through the member.

Career Highlights

F Peluso is associated with Baxter International Inc., a leading company in the healthcare sector. His work focuses on developing innovative solutions that enhance patient safety and improve healthcare outcomes.

Collaborations

Peluso has collaborated with notable colleagues, including Patrick R Balteau and Michael T Ling. These partnerships have contributed to the advancement of his research and the successful development of his patented technology.

Conclusion

F Peluso's contributions to antimicrobial technology through his innovative patent demonstrate his commitment to improving healthcare solutions. His work continues to influence the field and enhance the safety of medical practices.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…